| Financial Year |
March 31 2023 |
| Monetary Funds |
219,317,337.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
23,398,577.75 |
| Advances to Suppliers |
6,737,804.46 |
| Other Receivables |
1,260,759.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
160,723,888.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,987,737.98 |
| Total Current Assets |
432,188,110.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
331,083.35 |
| Fixed Assetes |
558,545,009.41 |
| Under-construction Projects |
250,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
35,544,943.37 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,138,377.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
14,610,200.70 |
| Other Non-Current Assets |
1,446,927.45 |
| Sub-Total of Non-Current Assets |
649,855,041.64 |
| Total Assets |
1,082,043,152.25 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
42,556,594.07 |
| Accounts Received In Advance |
916,472.07 |
| Employee Compensation Payable |
4,303,371.45 |
| Taxes Payable |
8,679,846.75 |
| Interest Payable |
1,652,957.57 |
| Dividend Payable |
-- |
| Other payables |
16,062,487.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,468,103.75 |
| Other Current Liabilities |
11,618,746.23 |
| Sub-Total of Current Liabilities |
131,897,887.32 |
| Long-term Loans |
6,495,145.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
837,734.89 |
| Sub-Total of Non-Current Liabilities |
33,235,116.76 |
| Total Liabilities |
165,133,004.08 |
| Paid-In Capital(Or Share Stock) |
321,120,000.00 |
| Capital Surplus |
465,934,924.36 |
| Surplus Reserve |
133,348,600.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
38,283,377.32 |
| Minority Stockholder's Interest |
-41,776,754.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
958,686,902.55 |
| Owner's Equity（Stockholder's Equity） |
916,910,148.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,082,043,152.25 |
